Immunology/Inflammation
Immunology/Inflammation(免疫及炎症)
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
- 5-Lipoxygenase(11)
- Papain(1)
- PGDS(1)
- PGE synthase(24)
- SIKs(12)
- IκB/IKK(67)
- AP-1(6)
- KEAP1-Nrf2(65)
- NOD1(1)
- TLR(140)
- NF-κB(241)
- Interleukin Related(171)
- 15-lipoxygenase(2)
- Others(63)
- Aryl Hydrocarbon Receptor(36)
- CD73(14)
- Complement System(58)
- Galectin(12)
- IFNAR(25)
- NO Synthase(77)
- NOD-like Receptor (NLR)(51)
- STING(110)
- Reactive Oxygen Species(465)
- Apoptosis(802)
- FKBP(20)
- eNOS(5)
- iNOS(29)
- nNOS(20)
- Glutathione(57)
- Adaptive Immunity(222)
- Allergy(130)
- Arthritis(34)
- Autoimmunity(190)
- Gastric Disease(101)
- Immunosuppressants(39)
- Immunotherapeutics(5)
- Innate Immunity(593)
- Pulmonary Diseases(119)
- Reactive Nitrogen Species(55)
- Reactive Sulfur Species(28)
- Specialized Pro-Resolving Mediators(50)
- Cyclic GMP-AMP Synthase(2)
- BCL6(3)
- CD20(3)
- CD22
- CD28(1)
- FAP(7)
- PSMA(7)
- Nuclear Factor of activated T Cells (NFAT)(1)
- Glycoprotein VI(1)
- Tim3(2)
- Hapten(1)
- Nectin-4(2)
Immunology/Inflammation 相关产品(4245)
- GC18489Neamine (hydrochloride)CAS: 15446-43-2
A common core molecule used in the synthesis of aminoglycoside antibiotics
- GC18498Cathepsin L Inhibitor (Z-FY-CHO)CAS: 167498-29-5纯度: >95.00% / >96.00% / >98.00%
Cathepsin L Inhibitor (Z-FY-CHO)是一种能够特异性抑制Cathepsin L活性的化合物(Ki=0.185nM),用于研究Cathepsin L在细胞内溶酶体功能和蛋白质降解过程中的作用。
- GC18522Phosphatidylserines (sodium salt)CAS: 383908-63-2纯度: >95.00%
A mixture of phosphatidylserines isolated from soy
- GC18552Lipoxin A4CAS: 89663-86-5纯度: >95.00%
Produced by the metabolism of 15-HETE or 15-HpETE with leukocytes
- GC18572Concanavalin ACAS: 11028-71-0纯度: >98.00% / 不显示
Concanavalin A属于concanamycin,这是一种从异色链霉菌中分离出来的大环内酯类抗生素,是液泡质子- atp酶(v-[H[+]] atp酶)的高活性和选择性抑制剂。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC18437 | Alternariol monomethyl ether | 23452-05-3 | - | |
A mycotoxin | ||||
| GC18443 | Acetyl-6-formylpterin | 29769-49-1 | - | |
An inhibitor of MAIT cell activation | ||||
| GC18449 | Cardanol monoene | 501-26-8 | - | |
An inhibitor of tyrosinase with anticancer properties | ||||
| GC18453 | Sulochrin | 519-57-3 | >98.00% | |
A fungal metabolite with antiallergenic, anti-angiogenic, and antiviral activity | ||||
| GC18458 | Terrein | 582-46-7 | >98.00% | |
A fungal metabolite with diverse biological activities | ||||
| GC18469 | Galactosylcerebrosides (bovine) | 85305-88-0 | >98.00% | |
A sphingolipid | ||||
| GC18478 | MPLA | 1246298-63-4 | - | |
| GC18487 | BC-1215 | 1507370-20-8 | >99.50% | |
An inhibitor of FBXO3 | ||||
| GC18488 | Cyclo(L-Leu-L-Trp) | 15136-34-2 | - | |
A diketopiperazine metabolite | ||||
| GC18489 | Neamine (hydrochloride) | 15446-43-2 | - | |
A common core molecule used in the synthesis of aminoglycoside antibiotics | ||||
| GC18498 | Cathepsin L Inhibitor (Z-FY-CHO) | 167498-29-5 | >95.00% / >96.00% / >98.00% | |
Cathepsin L Inhibitor (Z-FY-CHO)是一种能够特异性抑制Cathepsin L活性的化合物(Ki=0.185nM),用于研究Cathepsin L在细胞内溶酶体功能和蛋白质降解过程中的作用。 | ||||
| GC18499 | Erythromycin C | 1675-02-1 | - | |
An intermediate in the biosynthesis of erythromycin | ||||
| GC18510 | Siccanin | 22733-60-4 | - | |
An inhibitor of mitochondrial complex II | ||||
| GC18516 | (+)-Aeroplysinin-1 | 28656-91-9 | - | |
A sea sponge metabolite with diverse biological activities | ||||
| GC18517 | Diapocynin | 29799-22-2 | - | |
An inhibitor of NADPH-oxidase | ||||
| GC18522 | Phosphatidylserines (sodium salt) | 383908-63-2 | >95.00% | |
A mixture of phosphatidylserines isolated from soy | ||||
| GC18527 | 4'-hydroxy Flurbiprofen | 52807-12-2 | - | |
A major active metabolite of flurbiprofen | ||||
| GC18530 | CAY10616 | 586410-08-4 | - | |
Pro-apoptotic analog of resveratrol | ||||
| GC18533 | ZLDI-8 | 667880-38-8 | >98.50% | |
ZLDI-8 是一种 Notch 激活/切割酶 ADAM-17 抑制剂,可抑制 Notch 蛋白的切割。 ZLDI-8 降低促存活/抗凋亡和上皮间质转化 (EMT) 相关蛋白的表达。 ZLDI-8 还是一种竞争性且不可逆的酪氨酸磷酸酶 (Lyp) 抑制剂,IC50 为 31.6 μM,Ki 为 26.22 μM。 ZLDI-8 抑制 MHCC97-H 细胞的生长,IC50 为 5.32 μM。 | ||||
| GC18536 | Chartreusin | 6377-18-0 | - | |
An antibiotic with diverse biological activites | ||||
| GC18552 | Lipoxin A4 | 89663-86-5 | >95.00% | |
Produced by the metabolism of 15-HETE or 15-HpETE with leukocytes | ||||
| GC18556 | Degarelix (acetate) | 934016-19-0 | - | |
A synthetic GNRHR antagonist | ||||
| GC18566 | AZD 3147 | 1101810-02-9 | - | |
A dual mTORC1/mTORC2 inhibitor | ||||
| GC18572 | Concanavalin A | 11028-71-0 | >98.00% / 不显示 | |
Concanavalin A属于concanamycin,这是一种从异色链霉菌中分离出来的大环内酯类抗生素,是液泡质子- atp酶(v-[H[+]] atp酶)的高活性和选择性抑制剂。 | ||||
